Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04013334
Title MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Momotaro-Gene Inc.
Indications

malignant pleural mesothelioma

Therapies

MTG201 + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.